PreventiGene

PreventiGene is a pioneering force in biotechnology research, dedicated to revolutionizing the healthcare industry through advanced genetic solutions. PreventiGene operates as a subsidiary of Landa International Holding, focusing on the diagnosis and prevention of chronic diseases, notably breast cancer, utilizing cutting-edge genetic testing methodologies.

By leveraging artificial intelligence-based analysis, PreventiGene is poised to deliver personalized health programs tailored to individual family histories, ensuring proactive and specialized care. The company is committed to advancing genetic research and its practical applications, setting new standards in preventive healthcare. PreventiGene aims to empower individuals with the knowledge and tools necessary to manage their health proactively.

With a forward-thinking approach, PreventiGene continues to expand its capabilities and impact in the field of genetics and biotechnology. We invite the management of PreventiGene to create a customized and exclusive company showcase and product listing on our platform, enhancing their market presence and connecting with a broader audience.